| RS2133737748 |
ABCC8
|
Health Risk |
Pathogenic |
Hereditary hyperinsulinism, Hereditary hyperinsulinism |
| RS2133737797 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS2133737961 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2133738006 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2133738359 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS2133738442 |
ABCC8
|
Health Risk |
Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS2133738890 |
ANO5
|
Health Risk |
Pathogenic |
— |
| RS2133747497 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS2133747657 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS2133747827 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS2133748193 |
WDR11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 78 |
| RS2133750487 |
ANO5
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS2133750610 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133750928 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS2133750942 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133753509 |
PIDD1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 75 |
| RS2133754700 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS2133754743 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS2133754863 |
KCNQ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Cardiovascular phenotype |
| RS2133758146 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133758295 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133758446 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2133758591 |
KCNQ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome 1, Cardiovascular phenotype |
| RS2133759109 |
PIDD1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 75 |
| RS2133760795 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Cardiac arrhythmia |
| RS2133762469 |
GFRA1
|
Health Risk |
Pathogenic |
Renal hypodysplasia/aplasia 4, Renal hypodysplasia/aplasia 4 |
| RS2133764725 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133768184 |
PIDD1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 75 |
| RS2133773932 |
KCNC1
|
Health Risk |
Likely pathogenic |
— |
| RS2133774690 |
SLC6A5
|
Health Risk |
Likely pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS2133775660 |
SLC6A5
|
Health Risk |
Likely pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS2133777379 |
GLUD1
|
Health Risk |
Pathogenic |
Hyperinsulinism-hyperammonemia syndrome, Hyperinsulinism-hyperammonemia syndrome |
| RS2133778981 |
ANO5
|
Health Risk |
Likely pathogenic |
— |
| RS2133780268 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133780364 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133780371 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS2133782023 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133782104 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133782940 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS2133783113 |
CDKN1C
|
Health Risk |
Likely pathogenic |
— |
| RS2133783226 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS2133783249 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133783326 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS2133784672 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133784715 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133784748 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS2133785467 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133785530 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133785682 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133785693 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133785723 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133785734 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133785873 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133786067 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133786225 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133786397 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS2133786425 |
USH1C
|
Health Risk |
Pathogenic |
— |
| RS2133788446 |
SLC6A5
|
Health Risk |
Likely pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS2133788907 |
GLUD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinism-hyperammonemia syndrome, Hyperinsulinism-hyperammonemia syndrome |
| RS2133794292 |
PITX3
|
Health Risk |
Likely pathogenic |
Developmental cataract, Developmental cataract |
| RS2133794937 |
PITX3
|
Health Risk |
Pathogenic |
— |
| RS2133795361 |
ANO5
|
Health Risk |
Likely pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS2133796065 |
GLUD1
|
Health Risk |
Likely pathogenic |
— |
| RS2133797177 |
FANCF
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group F, Fanconi anemia |
| RS2133797345 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2133797511 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2133797515 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group F, Fanconi anemia complementation group F |
| RS2133798073 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2133798188 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group F, Fanconi anemia complementation group F |
| RS2133798401 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS2133798885 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group F |
| RS2133798927 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2133799697 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS2133800091 |
ANO5
|
Health Risk |
Pathogenic |
— |
| RS2133801342 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2133801703 |
PCDH15
|
Health Risk |
Pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2133805364 |
KCNC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive myoclonic epilepsy type 7, Seizure |
| RS2133808393 |
SLC6A5
|
Health Risk |
Likely pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS2133808512 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133809394 |
SLC6A5
|
Health Risk |
Pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS2133812056 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2133817680 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1F |
| RS2133818115 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2133818635 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2133819352 |
SLC6A5
|
Health Risk |
Likely pathogenic |
Hyperekplexia 3, Hyperekplexia 3 |
| RS2133823028 |
FGFR2
|
Health Risk |
Likely pathogenic |
Bilateral sensorineural hearing impairment, Bilateral sensorineural hearing impairment |
| RS2133823607 |
PAX2
|
Health Risk |
Pathogenic |
— |
| RS2133825383 |
UROS
|
Health Risk |
Pathogenic |
— |
| RS2133825396 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, Pfeiffer syndrome |
| RS2133833948 |
PAX2
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 7, Focal segmental glomerulosclerosis 7 |
| RS2133833987 |
PAX2
|
Health Risk |
Likely pathogenic |
PAX2-related disorder, PAX2-related disorder |
| RS2133834027 |
PAX2
|
Health Risk |
Likely pathogenic |
Renal coloboma syndrome, Renal coloboma syndrome |
| RS2133835239 |
FGFR2
|
Health Risk |
Likely pathogenic |
Acrocephalosyndactyly type I, Acrocephalosyndactyly type I |
| RS2133836340 |
PAX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal coloboma syndrome, Focal segmental glomerulosclerosis 7 |
| RS2133836347 |
PAX2
|
Health Risk |
Pathogenic |
Focal segmental glomerulosclerosis, Steroid-resistant nephrotic syndrome |
| RS2133836464 |
PAX2
|
Health Risk |
Likely pathogenic |
— |
| RS2133845071 |
UROS
|
Health Risk |
Pathogenic |
— |
| RS2133847468 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS2133849513 |
PNPLA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS2133849618 |
PNPLA2
|
Health Risk |
Pathogenic |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |